Logo image of AML.CA

AKWAABA MINING LTD (AML.CA) Stock Fundamental Analysis

Canada - TSX-V:AML - CA01021L2057 - Common Stock

0.135 CAD
-0.02 (-12.9%)
Last: 10/27/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, AML scores 1 out of 10 in our fundamental rating. AML was compared to 803 industry peers in the Metals & Mining industry. Both the profitability and financial health of AML have multiple concerns. AML does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AML has reported negative net income.
AML had a negative operating cash flow in the past year.
AML had negative earnings in each of the past 5 years.
AML had a negative operating cash flow in each of the past 5 years.
AML.CA Yearly Net Income VS EBIT VS OCF VS FCFAML.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.84%, AML is in the better half of the industry, outperforming 74.06% of the companies in the same industry.
AML has a Return On Equity of -4.08%. This is in the better half of the industry: AML outperforms 76.83% of its industry peers.
Industry RankSector Rank
ROA -3.84%
ROE -4.08%
ROIC N/A
ROA(3y)-4.15%
ROA(5y)-4.65%
ROE(3y)-4.52%
ROE(5y)-5.05%
ROIC(3y)N/A
ROIC(5y)N/A
AML.CA Yearly ROA, ROE, ROICAML.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

AML does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AML.CA Yearly Profit, Operating, Gross MarginsAML.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, AML has more shares outstanding
AML has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AML has a worse debt to assets ratio.
AML.CA Yearly Shares OutstandingAML.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AML.CA Yearly Total Debt VS Total AssetsAML.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

Based on the Altman-Z score of -0.36, we must say that AML is in the distress zone and has some risk of bankruptcy.
AML has a Altman-Z score of -0.36. This is in the lower half of the industry: AML underperforms 60.71% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that AML is not too dependend on debt financing.
AML has a Debt to Equity ratio of 0.03. This is comparable to the rest of the industry: AML outperforms 42.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.36
ROIC/WACCN/A
WACCN/A
AML.CA Yearly LT Debt VS Equity VS FCFAML.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

AML has a Current Ratio of 0.45. This is a bad value and indicates that AML is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AML (0.45) is worse than 72.42% of its industry peers.
A Quick Ratio of 0.45 indicates that AML may have some problems paying its short term obligations.
AML's Quick ratio of 0.45 is on the low side compared to the rest of the industry. AML is outperformed by 70.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
AML.CA Yearly Current Assets VS Current LiabilitesAML.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.70% over the past year.
EPS 1Y (TTM)15.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AML. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AML.CA Price Earnings VS Forward Price EarningsAML.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AML.CA Per share dataAML.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AML!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKWAABA MINING LTD

TSX-V:AML (10/27/2025, 7:00:00 PM)

0.135

-0.02 (-12.9%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners34.32%
Ins Owner ChangeN/A
Market Cap1.97M
Revenue(TTM)N/A
Net Income(TTM)-176.20K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.3
TBVpS0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.84%
ROE -4.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.15%
ROA(5y)-4.65%
ROE(3y)-4.52%
ROE(5y)-5.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5566.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z -0.36
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)12402.6%
Cap/Depr(5y)30607%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.93%
OCF growth 3YN/A
OCF growth 5YN/A

AKWAABA MINING LTD / AML.CA FAQ

What is the ChartMill fundamental rating of AKWAABA MINING LTD (AML.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to AML.CA.


Can you provide the valuation status for AKWAABA MINING LTD?

ChartMill assigns a valuation rating of 0 / 10 to AKWAABA MINING LTD (AML.CA). This can be considered as Overvalued.


Can you provide the profitability details for AKWAABA MINING LTD?

AKWAABA MINING LTD (AML.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for AML stock?

The financial health rating of AKWAABA MINING LTD (AML.CA) is 1 / 10.